Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 515 | 10,959 | 299 | 15,641 | 6,137 |
| Cost of Goods | 1,625 | 1,991 | 400 | 2,005 | 3,002 |
| Gross Profit | -1,110 | 8,968 | -101 | 13,636 | 3,135 |
| Operating Expenses | 16,766 | 17,471 | 17,396 | 13,576 | 8,736 |
| Operating Income | -17,251 | -7,512 | -17,097 | 65 | -5,599 |
| Other Income | 642 | 493 | 172 | 172 | -175 |
| Pre-tax Income | -16,609 | -7,019 | -16,925 | 237 | -5,774 |
| Net Income Continuous | -16,609 | -7,019 | -16,925 | 237 | -5,774 |
| Net Income | $-16,609 | $-7,019 | $-16,925 | $237 | $-5,774 |
| EPS Basic Total Ops | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 |
| EPS Basic Continuous Ops | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 |
| EPS Diluted Total Ops | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 |
| EPS Diluted Continuous Ops | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 |
| EBITDA(a) | $-16,213 | $-6,410 | $-16,021 | $838 | $-4,939 |